Wednesday, January 27, 2016

Massachusetts Examining Gilead's Hepatitis C Drug Pricing

The Massachusetts attorney general’s office is investigating whether Gilead Sciences Inc.’s pricing of its hepatitis C drugs is unlawful, according to a letter from the prosecutor that also asked the company to lower its prices.

from WSJ.com: US Business http://ift.tt/1noGmgU
via IFTTT

No comments:

Post a Comment